4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-001476
Chief Financial Officer sold 8,333 shares at $11.98 ($99,829)
- Chief Financial Officer acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-01-01 | Grant or award | +85,000 | 395,815 | D | ||
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-01-02 | Sale | −8,333 | $11.98 | $99,829 | 387,482 | D |
| Open-market sales · 8,333 sh · avg $11.98 · $99,829 | |||||||
Loading xslF345X03/doc4.xml…